Restoration of Noradrenergic Function in Parkinson's Disease Model Mice. (May 2021)

• Record Type: Journal Article
• Authors: Cui, Kui; Yang, Fan; Tufan, Turan; Raza, Muhammad U.; Zhan, Yanqiang; Fan, Yan; Zeng, Fei; Brown, Russell W.; Price, Jennifer B.; Jones, Thomas C.; Miller, Gary W.; Zhu, Meng-Yang
• Is Part Of: ASN neuro. Volume 13(2021)
• Publication Date: 2021-05
• Subjects: locus coeruleus -- norepinephrine -- tyrosine hydroxylase -- dopamine -- dopamine β-hydroxylase -- Morris water maze; Neurosciences -- Periodicals; Molecular neurobiology -- Periodicals; 573.8
• DOI: 10.1177/17590914211009730
• Languages: English
• ISSNs: 1759-0914

Abstract

Dysfunction of the central noradrenergic and dopaminergic systems is the primary neurobiological characteristic of Parkinson's disease (PD). Importantly, neuronal loss in the locus coeruleus (LC) that occurs in early stages of PD may accelerate progressive loss of dopaminergic neurons. Therefore, restoring the activity and function of the deficient noradrenergic system may be an important therapeutic strategy for early PD. In the present study, the lentiviral constructions of transcription factors Phox2a/2b, Hand2 and Gata3, either alone or in combination, were microinjected into the LC region of the PD model VMAT2 Lo mice at 12 and 18 month age. Biochemical analysis showed that microinjection of lentiviral expression cassettes into the LC significantly increased mRNA levels of Phox2a, and Phox2b, which were accompanied by parallel increases of mRNA and proteins of dopamine β-hydroxylase (DBH) and tyrosine hydroxylase (TH) in the LC. Furthermore, there was considerable enhancement of DBH protein levels in the frontal cortex and hippocampus, as well as enhanced TH protein levels in the striatum and substantia nigra. Moreover, these manipulations profoundly increased norepinephrine and dopamine concentrations in the striatum, which was followed by a remarkable improvement of the spatial memory and locomotor behavior. These results reveal that over-expression of these transcription factors in the LC improves noradrenergic and dopaminergic activities and functions in this rodent model of PD. It provides the necessary groundwork for the development of gene therapies of PD, and expands our understanding of the link between the LC-norepinephrine and dopamine systems during the progression of PD.